fbpx
Portrait of Dina Y. Gewaily MD, MS, FAAO

Dina Y. Gewaily MD, MS, FAAO

Retinal Specialist
Lancaster, Pennsylvania

Dina Y. Gewaily MD, MS, FAAO an Ophthalmologist with Lancaster Retina Specialist

Share Profile
Specialty Retinal Specialist
Industry Health Services
Organization Lancaster Retina Specialists
Location Lancaster, Pennsylvania

About Dina Y. Gewaily MD, MS, FAAO

Dina Y. Gewaily MD, MS, FAAO an Ophthalmologist with Lancaster Retina Specialist

Career Accomplishments

  • National Siemens-Westinghouse Science and Technology Competition Semi-finalist, 2000
  • Invited Peer Reviewer 2013, RETINA: The Journal of Retinal and Vitreous Diseases
  • New York State Science Talent Search, High Honors, 2001
  • Invited Peer Reviewer 2014, Cochrane Eye and Vision Group (CEVG)
  • Intel Science Talent Search National Semi-finalist, 2001
  • Received Honors in every pre-clinical medical school course (Years I/II) at Brown Medical School
  • First female surgical retina fellow in the history of the University of Pennsylvania’s Scheie Eye Institute.

Press & Recognition

Professional Career

Penn’s Scheie Eye Institute

Adjunct faculty

United States of America

Assistant Professor of Ophthalmology

United States of America

Education & Training

B.A.

Education Level: B.A.

Institution: Brown University

United States of America

M.S.

Education Level: M.S.

Institution: Brown University

United States of America

M.D.

Education Level: M.D.

Institution: Brown University

United States of America

Residency

Education Level: Residency

Institution: Scheie Eye Institute

United States of America

Vitreo-retinal Diseases and Surgery

Education Level: Fellowship

Institution: Scheie Eye Institute

Pennsylvania, United States of America

Published Works

  • Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial — 2014
    Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial
  • Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial (CATT).” — 2013
    Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial (CATT).”
  • Gewaily D, Newcomb C, Levy-Clarke G, Nussenblatt R, Rosenbaum J, Suhler E, Thorne J, Foster CS, Jabs D, Kempen J. “Remission of intermediate uveitis: rate and predictive factors.” ARVO Confer — 2012
    Gewaily D, Newcomb C, Levy-Clarke G, Nussenblatt R, Rosenbaum J, Suhler E, Thorne J, Foster CS, Jabs D, Kempen J. “Remission of intermediate uveitis: rate and predictive factors.” ARVO Confer
  • Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history — 2012
    Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history
  • Peto T, Wolf-Schnurrbusch U, Powling A, Gewaily D, Marshall K. “Review of patients in Tower Hamlets with poor vision recorded in diabetic retinopathy screening.” 19 th European Association fo — 2009
    Peto T, Wolf-Schnurrbusch U, Powling A, Gewaily D, Marshall K. “Review of patients in Tower Hamlets with poor vision recorded in diabetic retinopathy screening.” 19 th European Association fo
  • Gewaily D, Greenberg PB, Anderson K. “Ophthalmology in late 19 th century America.” Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology. Atlanta, — 2008
    Gewaily D, Greenberg PB, Anderson K. “Ophthalmology in late 19 th century America.” Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology. Atlanta,
  • Gewaily D, Kane S, Al-Aswad LA. “Modification of Ahmed seton procedure in two pediatric cases.” Pediatric Grand Rounds presentation. Columbia University College of Physicians and Surgeons/Edw — 2008
    Gewaily D, Kane S, Al-Aswad LA. “Modification of Ahmed seton procedure in two pediatric cases.” Pediatric Grand Rounds presentation. Columbia University College of Physicians and Surgeons/Edw
  • Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion: a Cochrane systematic review.” 11 th Annual Residents Researc — 2008
    Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion: a Cochrane systematic review.” 11th Annual Residents Research
  • Gewaily D, Greenberg PB, Anderson K. “The great imitator: ocular manifestations of syphilis in 1897.” The New England Ophthalmological Society Meeting. Boston, MA. May 2008. — 2008
    Gewaily D, Greenberg PB, Anderson K. “The great imitator: ocular manifestations of syphilis in 1897.” The New England Ophthalmological Society Meeting. Boston, MA. May 2008.
  • Katsoulakis N, Gewaily D, Filippopoulos T, Rao S, Anderson K, Greenberg PB. “Accuracy of predicted refractive error in resident-performed cataract surgery using partial coherence interferomet — 2008
    Katsoulakis N, Gewaily D, Filippopoulos T, Rao S, Anderson K, Greenberg PB. “Accuracy of predicted refractive error in resident-performed cataract surgery using partial coherence interferomet
  • Gewaily D, Greenberg PB. “Intravitreal steroids for macular edema secondary to central retinal vein occlusion.” 15th Annual Lifespan/Brown Research Celebration. Providence, RI. November 2007. — 2007
    Gewaily D, Greenberg PB. “Intravitreal steroids for macular edema secondary to central retinal vein occlusion.” 15th Annual Lifespan/Brown Research Celebration. Providence, RI. November 2007.
  • Gewaily D, Haggag M. “Immunotherapy for allergic conjunctivitis: eyedrops or sublingual approach?” The Society of Microbiology and Immunology National conference. Cairo, Egypt. April 2007. — 2007
    Gewaily D, Haggag M. “Immunotherapy for allergic conjunctivitis: eyedrops or sublingual approach?” The Society of Microbiology and Immunology National conference. Cairo, Egypt. April 2007.
  • Gewaily D, Haggag M. “A naturally-based and cost-effective approach to the treatment of allergic conjunctivitis.” 4th Annual Unite for Sight conference. Stanford U. School of Medicine. Palo A — 2007
    Gewaily D, Haggag M. “A naturally-based and cost-effective approach to the treatment of allergic conjunctivitis.” 4th Annual Unite for Sight conference. Stanford U. School of Medicine. Palo A
  • Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 12 th International Sy — 2006
    Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 12th International Sym
  • Gewaily D, Seo Y, Samuilov V, Sokolov J, Rafailovich M. “Study of DNA morphology in a small droplet during evaporation.” Material Research Society National Symposium. Boston, MA. November 200 — 2001
    Gewaily D, Seo Y, Samuilov V, Sokolov J, Rafailovich M. “Study of DNA morphology in a small droplet during evaporation.” Material Research Society National Symposium. Boston, MA. November 200
  • Russell S, Bennett J, Wellman JA, …[insert coauthors]…Gewaily D, ...Wright JF, High KA, Maguire AM. “Phase 3 efficacy and safety study of voretigene neparvovec (AAV2- hRPE65v2) in subjects wi — 2017
    Russell S, Bennett J, Wellman JA, …[insert coauthors]…Gewaily D, ...Wright JF, High KA, Maguire AM. “Phase 3 efficacy and safety study of voretigene neparvovec (AAV2-hRPE65v2) in subjects wit
  • Zhou H, Gewaily D, Ahn S, et al. “Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.” Acce — 2017
    Zhou H, Gewaily D, Ahn S, et al. “Sequence analysis and functional characterization of full-length hepatitis B virus genomes from Korean cirrhotic patients with or without liver cancer.” Acce
  • Zhou Q, Daniel E, Grunwald J, Maguire M, Gewaily D, Martin D, Ying G, on behalf of CATT Research Group. “Association between pseudodrusen and delayed patchy choroidal filling in the Compariso — 2016
    Zhou Q, Daniel E, Grunwald J, Maguire M, Gewaily D, Martin D, Ying G, on behalf of CATT Research Group. “Association between pseudodrusen and delayed patchy choroidal filling in the Compariso
  • Kempen J, Gewaily D, Newcomb C, et al. “Remission of intermediate uveitis: incidence and predictive factors.” Am J Ophthalmol.  2016 Jan 6. pii: S0002-9394(16)30002-2. doi: 10.1016/j.ajo.2015 — 2016
    Kempen J, Gewaily D, Newcomb C, et al. “Remission of intermediate uveitis: incidence and predictive factors.” Am J Ophthalmol.  2016 Jan 6. pii: S0002-9394(16)30002-2. doi: 10.1016/j.ajo.2015
  • Gewaily D, Muthuswamy K, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.” Cochrane Database of Systematic Reviews 2015, — 2015
    Gewaily D, Muthuswamy K, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.” Cochrane Database of Systematic Reviews 2015,
  • Brodie FL , Charlson ES , Aleman TS , Salvo RT , Gewaily DY, Lau MK , Farren ND , Engelhard SB , Pistilli M , Brucker AJ . “Obstructive sleep apnea and central serous chorioretinopathy.” Reti — 2014
    Brodie FL , Charlson ES , Aleman TS , Salvo RT , Gewaily DY, Lau MK , Farren ND , Engelhard SB , Pistilli M , Brucker AJ . “Obstructive sleep apnea and central serous chorioretinopathy.” Reti
  • Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial — 2014
    Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial
  • Aleman T, Brodie F, Garvin C, Gewaily D, Ficicioglu C, Mills M, Forbes B, Maguire A, Davidson S. “Retinal structure in Cobalamin C Disease: mechanistic and therapeutic implications.” Ophthalm — 2014
    Aleman T, Brodie F, Garvin C, Gewaily D, Ficicioglu C, Mills M, Forbes B, Maguire A, Davidson S. “Retinal structure in Cobalamin C Disease: mechanistic and therapeutic implications.” Ophthalm
  • Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history — 2012
    Huang W, Wright A, Roman A, Cideciyan A, Manson F, Gewaily D, Schwartz S, Sadigh S, Limberis M, Bell P, Wilson J, Swaroop A, Jacobson S. “X-linked RP caused by RPGR mutations: natural history
  • Huang W, Roman A, Cideciyan A, Gewaily D,  Limberis A,  Bell P, Wilson J,  Wright A, Swaroop A,  Jacobson S. RPGR-associated retinal degeneration in human x-linked RP and a murine model. Inve — 2012
    Huang W, Roman A, Cideciyan A, Gewaily D,  Limberis A,  Bell P, Wilson J,  Wright A, Swaroop A,  Jacobson S. RPGR-associated retinal degeneration in human x-linked RP and a murine model. Inve
  • Gewaily D, Greenberg PB. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No — 2009
    Gewaily D, Greenberg PB. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No
  • Tsai A, Kawai S, Kwei K, Gewaily D, Hutter A, Tong D, Li J, Wands J, Tong S. “Chimeric constructs between two Hepatitis B virus genomes confirm transcriptional impact of core promoter mutatio — 2009
    Tsai A, Kawai S, Kwei K, Gewaily D, Hutter A, Tong D, Li J, Wands J, Tong S. “Chimeric constructs between two Hepatitis B virus genomes confirm transcriptional impact of core promoter mutatio
  • Gewaily D. Associate Author. USMLERx Flash Cards for First Aid for the USMLE Step 1, 2nd ed, 2008. USMLERx Step 1 Website. Available at: http://www.usmlerx.com . — 2008
    Gewaily D. Associate Author. USMLERx Flash Cards for First Aid for the USMLE Step 1, 2nd ed, 2008. USMLERx Step 1 Website. Available at: http://www.usmlerx.com .
  • Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion [protocol].” Cochrane Database of Systematic Reviews 2008, Iss — 2008
    Gewaily D, Greenberg PB. “Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion [protocol].” Cochrane Database of Systematic Reviews 2008, Iss
  • Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 57 th Annual Meeting o — 2006
    Kim K, Tang X, Gewaily D, Li J, Wands J, Tong S. “Opposing effects of two naturally occurring mutations in Hepatitis B virus core protein on 2 nd strand DNA synthesis.” 57th Annual Meeting of
  • Gewaily D, Wands J, Tong S. “Hepatitis B virus isolated from liver cancer patients may possess increased replication capacity.” Brown University Sciences Library. 2006. 1- Size 1- N M2006 G49 — 2006
    Gewaily D, Wands J, Tong S. “Hepatitis B virus isolated from liver cancer patients may possess increased replication capacity.” Brown University Sciences Library. 2006. 1- Size 1- N M2006 G49
  • Fang X, Li B, Gewaily D, Sokolov J, Rafailovich M. “Hildebrand solubility parameters measurement via sessile drops evaporation.” Appl. Phys. Lett. 2005; 87. — 2005
    Fang X, Li B, Gewaily D, Sokolov J, Rafailovich M. “Hildebrand solubility parameters measurement via sessile drops evaporation.” Appl. Phys. Lett. 2005; 87.
  • A Phase 2, double-masked, randomized, parallel-group study to investigate the safety, tolerability and efficacy of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-re — 2015
    A Phase 2, double-masked, randomized, parallel-group study to investigate the safety, tolerability and efficacy of GSK933776 in adult patients with geographic atrophy (GA) secondary to age-re
  • Study of the choroid in patients with obstructive sleep apnea (OSA) – a prospective pilot feasibility study. IRB Protocol # 816732. “CSR/OSA.” Sub-investigator. — 2015
    Study of the choroid in patients with obstructive sleep apnea (OSA) – a prospective pilot feasibility study. IRB Protocol # 816732. “CSR/OSA.” Sub-investigator.
  • A randomized, double-masked, placebo-controlled study of the safety and efficacy of Gevokizumab and the treatment of subjects with non-infectious intermediate, posterior, or pan-uveitis curre — 2015
    A randomized, double-masked, placebo-controlled study of the safety and efficacy of Gevokizumab and the treatment of subjects with non-infectious intermediate, posterior, or pan-uveitis curre
  • Multi-center, randomized, single-masked phase 2 study of intravitreal sirolimus in the treatment of central geographic atrophy associated with age-related macular degeneration. IRB Protocol # — 2015
    Multi-center, randomized, single-masked phase 2 study of intravitreal sirolimus in the treatment of central geographic atrophy associated with age-related macular degeneration. IRB Protocol #
  • A randomized, placebo-controlled, parallel-group, double blind efficacy and safety trial of MK-8931 in subjects with mild to moderate Alzheimers disease. Protocol No. MK-8931- 017-03; also kn — 2015
    A randomized, placebo-controlled, parallel-group, double blind efficacy and safety trial of MK-8931 in subjects with mild to moderate Alzheimers disease. Protocol No. MK-8931-017-03; also kno
  • A randomized, placebo-controlled, parallel-group, double-blind efficacy and safety trial of MK-8931 with a long term double-blind extension in subjects with mild to moderate Alzheimers diseas — 2015
    A randomized, placebo-controlled, parallel-group, double-blind efficacy and safety trial of MK-8931 with a long term double-blind extension in subjects with mild to moderate Alzheimers diseas
  • A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intra-vitreal administration of Fovista (Anti PDGF-B pegylated aptamer) administered in combinati — 2015
    A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intra-vitreal administration of Fovista (Anti PDGF-B pegylated aptamer) administered in combinati
  • Study of comparative treatments for REtinal Vein Occlusion 2 (SCORE2): A multi-center, prospective, randomized, phase III, non-inferiority trial of eyes with macular edema secondary to centra — 2015
    Study of comparative treatments for REtinal Vein Occlusion 2 (SCORE2): A multi-center, prospective, randomized, phase III, non-inferiority trial of eyes with macular edema secondary to centra
  • Gewaily D. “Mystery Case.” Atlantic Coast Retina Club (ACRC) and Macula Society 2014 Meeting. Wills Eye Institute, Philadelphia, PA. January 2014. — 2014
    Gewaily D. “Mystery Case.” Atlantic Coast Retina Club (ACRC) and Macula Society 2014 Meeting. Wills Eye Institute, Philadelphia, PA. January 2014.
  • Grunwald JE, Gewaily D, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial — 2014
    Grunwald JE, Gewaily D, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial
  • Kempen J, Gewaily D, Artornsombudh P, SITE Cohort Study Research Group, et al. “Factors predictive of remission of new-onset anterior uveitis and of intermediate uveitis.” Podium presentation — 2014
    Kempen J, Gewaily D, Artornsombudh P, SITE Cohort Study Research Group, et al. “Factors predictive of remission of new-onset anterior uveitis and of intermediate uveitis.” Podium presentati
  • Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial — 2014
    Gewaily D, Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Ostroff CP, Fine SL. “Delayed patchy choroidal filling in the Comparison of Age Related Macular Degeneration Treatment Trial
  • Maguire A, [insert co-authors], Gewaily D, et al. Subretinal Injection Technique of Retinal Gene Therapy Applications. Macula Society. Miami Beach, FL. Feb. 24-27, 2016. — 2016
    Maguire A, [insert co-authors], Gewaily D, et al. Subretinal Injection Technique of Retinal Gene Therapy Applications. Macula Society. Miami Beach, FL. Feb. 24-27, 2016.

Contact Dina Y. Gewaily MD, MS, FAAO

Lancaster Retina Specialists

Lancaster, Pennsylvania

Use the form to contact Dina Y. Gewaily MD, MS, FAAO through the Global Directory of Who's Who.

PROFILE SUMMARY

Professional Summary

Dina Y. Gewaily MD, MS, FAAO an Ophthalmologist with Lancaster Retina Specialist